Donald A. Bergstrom - 14 Jun 2021 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Donald Bergstrom
Issuer symbol
FUSN
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2022, 19:03:15 UTC
Previous filing
07 Jun 2021
Next filing
17 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +17,000 $0.000000 17,000 14 Jun 2022 Common Stock 17,000 $3.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option fully vests on the earlier of (i) June 14, 2023 or (ii) the 2023 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.